Avitide
Custom affinity purification reagents and products for bioprocess optimization
- Sector
- Biotech
- Headquarters
- LEBANON, NH
- Founded
- 2012
- Latest Form D
- $10M, Oct 2019
- Total capital
- $40.9M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $40.9M
- 7 Form D · last Oct 2019
- 84 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 1
- 24 pending · first 2025
- Rank in peer group#17 of 54
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 7th filing$10M
- Private capital raisedForm D · SEC · 6th filing$6.2M
- Private capital raisedForm D · SEC · 5th filing$4M
- Private capital raisedForm D · SEC · 4th filing$12M
- Private capital raisedForm D · SEC · 3rd filing$3.8M
- Private capital raisedForm D · SEC · 2nd filing$3.4M
- Private capital raisedForm D · SEC · 1st filing$1.4M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 54 peers
Line = medianBiotech · Material
- Granted patents#17 · top 31%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Ajay RoyanDirectorNamed in SEC Form D filings
- Claudio NessiDirectorNamed in SEC Form D filings
- Colin GreensponDirectorNamed in SEC Form D filings
- Errik AndersonDirectorNamed in SEC Form D filings
- Ian RatcliffeDirectorNamed in SEC Form D filings
- Jonathan ShellerExecutive OfficerNamed in SEC Form D filings
Show all 15 people
- Jon ShellerExecutive OfficerNamed in SEC Form D filings
- Kevin IsettExecutive Officer, DirectorNamed in SEC Form D filings
- Kevin IssettExecutive Officer, DirectorNamed in SEC Form D filings
- Michael RossDirectorNamed in SEC Form D filings
- Philip FerneauDirectorNamed in SEC Form D filings
- Rishi GuptaDirectorNamed in SEC Form D filings
- Scott KennedyExecutive OfficerNamed in SEC Form D filings
- Tillman GerngrossDirectorNamed in SEC Form D filings
- Warren KettExecutive OfficerNamed in SEC Form D filings
What it has protected
USPTO · 1 granted of 25- GrantedAAV9 Affinity AgentsUSPTOUS 12,312,607
- PendingCH1 Domain Affinity Ligands And AgentsUSPTOApplication 18721454
- PendingAAV2 Affinity AgentsUSPTOApplication 18277683
Show all 25 patent records
- AAV9 Affinity AgentsMay 27, 2025 · US 12,312,607Granted
- CH1 Domain Affinity Ligands And AgentsFeb 20, 2025 · Application 18721454Pending
- AAV2 Affinity AgentsApr 25, 2024 · Application 18277683Pending
- Affinity Ligand Libraries Of Three-helix Bundle Proteins And Uses ThereofJan 25, 2024 · Application 18031808Pending
- CH1 Domain Affinity Ligands And AgentsApplication 63308707Pending
- CH1 Domain Affinity Ligands And AgentsApplication 63293718Pending
- CH1 Domain Affinity Ligands And AgentsApplication 63407563Pending
- Affinity AgentsApplication PCTUS2023031832Pending
- CH1 Domain Affinity Ligands And AgentsApplication PCTUS2022053926Pending
- Affinity AgentsApplication 63428949Pending
- Affinity AgentsApplication 63424009Pending
- Affinity Ligand Libraries Of Three-helix Bundle Proteins And Uses ThereofApplication PCTUS2021054874Pending
- AAV8 Affinity AgentsApplication PCTUS2021054870Pending
- Affinity AgentsApplication 63188229Pending
- Affinity AgentsApplication 63159336Pending
- Affinity AgentsApplication 63151622Pending
- Affinity AgentsApplication 63091207Pending
- Affinity AgentsApplication 63091201Pending
- Affinity AgentsApplication PCTUS2020034340Pending
- Affinity AgentsApplication 62949878Pending
- Affinity AgentsApplication 63405301Pending
- Affinity AgentsApplication 62852717Pending
- Affinity AgentsApplication 63393538Pending
- Affinity AgentsApplication PCTUS2022019839Pending
- AAV2 Affinity AgentsApplication PCTUS2022017252Pending
Related companies, and why
- BIOPHY, INC.Similar federal contract value in Biotech · null in contracts
- Deciduous TherapeuticsSimilar federal contract value in Biotech · null in contracts
- AdimabSimilar federal contract value in Biotech · null in contracts
- NEXGENIA, INC.Similar federal contract value in Biotech · null in contracts
- Terremoto BiosciencesSimilar federal contract value in Biotech · null in contracts
- NephroDI Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .